Infectious Diseases News and Research

RSS

Convalescent plasma therapy may reduce mortality rate in patients with H1N1 infection: Study

A study published in the February 15 issue of Clinical Infectious Diseases suggests that convalescent plasma may reduce the death rate in patients severely ill with this type of influenza.

19 Jan 2011

Positive preliminary results from Soligenix's SGX202 in GARS model

Soligenix, Inc., a late-stage biopharmaceutical company, announced today promising preliminary results from a preclinical study of SGX202 in a canine gastrointestinal acute radiation syndrome model.

19 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

Women's Health Congress to explore mammography controversy

The ongoing controversy about the appropriate age, frequency, and patient benefit of mammography will be explored at the upcoming 19th Annual Congress on Women's Health, April 1-3, 2011 in Washington DC.

18 Jan 2011

Vaccine to prevent MRSA infections after bone and joint surgery

University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.

18 Jan 2011

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.

18 Jan 2011

Study reports long-term complications in childhood survivors of bacterial meningitis

Nearly half of children who survive an episode of bacterial meningitis experience persistent behavioral, intellectual, or other complications, reports a study in the January issue of The Pediatric Infectious Disease Journal.

14 Jan 2011

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."

14 Jan 2011

BioCryst reports positive results from peramivir Phase 3 study in influenza

BioCryst Pharmaceuticals, Inc. today announced top-line results from one of its two Phase 3 studies of intravenous (i.v.) peramivir for the treatment of patients hospitalized with influenza, and provided an update regarding its peramivir program.

13 Jan 2011

The past, present and future of anthrax research

Few strands of bacteria have achieved such a central place in public consciousness as Bacillus anthracis, the bacteria which causes Anthrax. While today it is a feared weapon of bioterrorism Bacillus anthracis has played a significant historical role, especially through the research of the celebrated 19th century scientists Robert Koch and Louis Pasteur, in shaping our understanding of infectious diseases and immunology

13 Jan 2011

Antibiotics need to be used only when diagnosis of acute ear infection is certain

A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.

13 Jan 2011

Washington Post examines theories on climate change's potential impact on disease spread

The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.

13 Jan 2011

Antibiotics for ear infection in kids better than watchful waiting: Study

Findings from two latest clinical trials reveal that a young child with ear infections recovers faster and more completely if doctors give antibiotics right away rather than waiting to see if the kid get better on his/her own. One of the studies was in the U.S. and one in Finland. Earlier it has been debated that for young children with middle ear infections or otitis media whether immediate antibiotic treatment was better than watchful waiting. Current treatment recommendations in the U.S., Canada, and Europe allow for a watch-and-wait approach to suspected middle ear infections in young children. Change is coming, predicts study leader Alejandro Hoberman, MD, of Children’s Hospital of Pittsburgh.

12 Jan 2011

US most susceptible to brand erosion post patent expiry

On average, small molecule brands in the US experienced the greatest degree of brand erosion following patent expiry and exposure to direct generic competition, according to a new report from independent market analyst, Datamonitor.

12 Jan 2011

University of Minnesota places order for Bruker's ultra-high field NMR spectrometers

Bruker announces an order valued at over $7.5 million from the University of Minnesota for its new Nuclear Magnetic Resonance (NMR) laboratory, including ultra-high field Avance™ III 900 and Avance™ III 850 NMR spectrometers. The systems will be installed in the newly constructed and greatly expanded NMR Facility at the University of Minnesota.

12 Jan 2011

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

12 Jan 2011

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

12 Jan 2011

Researchers: Docs often use treatments that have little scientific support

Even when following medical guidelines to the letter, doctors often use treatments that have little or no scientific support, U.S. researchers said Monday.

11 Jan 2011

Medical aid workers should take pre-travel precautions to prevent disease transmission

Guidance about pre-travel precautions and preventive measures are highlighted in the December 1, 2010 issue of Clinical Infectious Diseases, written by clinicians and researchers at the Uniformed Services University of the Health Sciences and their partners from the University of Texas Health Sciences Center, Naval Medical Research Center and others.

11 Jan 2011

OraSure to introduce QuickFlu test for detection of type A and type B influenza

OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.

11 Jan 2011

Infectious Diseases News and Research

Convalescent plasma therapy may reduce mortality rate in patients with H1N1 infection: Study

Positive preliminary results from Soligenix's SGX202 in GARS model

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Women's Health Congress to explore mammography controversy

Vaccine to prevent MRSA infections after bone and joint surgery

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

Study reports long-term complications in childhood survivors of bacterial meningitis

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

BioCryst reports positive results from peramivir Phase 3 study in influenza

The past, present and future of anthrax research

Antibiotics need to be used only when diagnosis of acute ear infection is certain

Washington Post examines theories on climate change's potential impact on disease spread

Antibiotics for ear infection in kids better than watchful waiting: Study

US most susceptible to brand erosion post patent expiry

University of Minnesota places order for Bruker's ultra-high field NMR spectrometers

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Lancet series examines health challenges in India

Researchers: Docs often use treatments that have little scientific support

Medical aid workers should take pre-travel precautions to prevent disease transmission

OraSure to introduce QuickFlu test for detection of type A and type B influenza

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News